Trials / Completed
CompletedNCT02135315
Intensive Arterial Pressure Control in Acute Coronary Syndrome
One-year Outcome of Intensive Versus Standard Blood Pressure Treatment in Non-ST Elevation Acute Coronary Syndrome: A Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,500 (actual)
- Sponsor
- University of Monastir · Academic / Other
- Sex
- All
- Age
- 30 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The intensive arterial pressure control in acute coronary syndrome (ACS) during the first 24 hours can improve the prognosis in the short and long term. the study compare two treatment strategies (standard and intensive treatment) to assess their efficacy and safety in the treatment of acute coronary syndrome.
Detailed description
Acute coronary syndrome is often associated with arterial pressure elevation which are deleterious for the heart and needs urgent intervention to lower the blood pressure to the required values, however there is no clear recommendations concerning the treatment intensity in this situation. The investigators know that high arterial pressure increases the oxygen myocardial consumption and it is deleterious in acute coronary syndrome, so , it is logical to reduce intensively this pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isosorbide Dinitrate | administration of continuous intravenous isosorbide dinitrate to obtain a SBP between 110 and 120 mmHg. After 2 hours from the start of treatment and if the blood pressure goal is not achieved, labetalol is used |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2014-05-09
- Last updated
- 2022-08-24
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT02135315. Inclusion in this directory is not an endorsement.